Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr312 Inhibitors

Inhibition of the olfactory receptor Olfr312 can be achieved through a variety of mechanisms, predominantly involving the alteration of receptor conformation or the blocking of active sites essential for odorant binding and activation. The use of certain heavy metals is a prime example; they bind to the receptor sites with a higher affinity than the natural ligands, effectively preventing these ligands from interacting with Olfr312. This competitive binding can lead to a structural change in the receptor, which is crucial for its activation by odorants. Similarly, other metal compounds are capable of binding to the thiol groups in proteins, which could change the receptor's conformation, thus inhibiting the proper functioning of Olfr312. These alterations in receptor structure not only prevent the proper binding of odorant molecules but can also impede the subsequent signaling cascade that would normally result from receptor activation.

Some compounds exert their inhibitory effect by interacting with the cell membrane environment where Olfr312 is situated, influencing the receptor's ability to function as intended. For instance, alterations in membrane fluidity and the ionic balance within the receptor's microenvironment could indirectly inhibit receptor activation by affecting the spatial orientation and mobility of Olfr312. Additionally, certain metal ions may displace other essential metal ions in the receptor structure, leading to a disruption in the normal function and signaling of Olfr312. In essence, these inhibitors utilize a myriad of strategies to impede the activation of Olfr312, whether through direct competition, structural modification, or indirect effects on the receptor's cellular context, ensuring that the receptor's capacity to detect and respond to odorants is diminished.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Zinc

7440-66-6sc-213177
100 g
$47.00
(0)

Binds to olfactory receptor sites, altering receptor conformation and preventing binding of odorant molecules to Olfr312.

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$45.00
$120.00
$185.00
3
(1)

Competitively binds to olfactory receptors, changing their structure and impeding the ability of odorant molecules to interact with Olfr312.

Cadmium chloride, anhydrous

10108-64-2sc-252533
sc-252533A
sc-252533B
10 g
50 g
500 g
$55.00
$179.00
$345.00
1
(1)

Alters olfactory receptor activity by binding to receptor sites and blocking odorant molecule interaction with Olfr312.

Nickel Sulfate

7786-81-4sc-507407
5 g
$63.00
(0)

Competes with odorant molecules for binding sites on olfactory receptors, inhibiting the normal function of Olfr312.

Silver nitrate

7761-88-8sc-203378
sc-203378A
sc-203378B
25 g
100 g
500 g
$112.00
$371.00
$1060.00
1
(1)

Interacts with sulfhydryl groups on olfactory receptors, modifying the receptor structure and inhibiting Olfr312 activation.

Cobalt(II) chloride

7646-79-9sc-252623
sc-252623A
5 g
100 g
$63.00
$173.00
7
(1)

Can displace other metal ions in olfactory receptors, potentially disrupting the normal function and activation of Olfr312.

Manganese(II) chloride beads

7773-01-5sc-252989
sc-252989A
100 g
500 g
$19.00
$30.00
(0)

May interfere with metal ion balance in olfactory receptors, affecting the conformation and signaling of Olfr312.

Lead(II) Acetate

301-04-2sc-507473
5 g
$83.00
(0)

Disrupts protein function by binding to specific sites, potentially altering the configuration of Olfr312 and blocking odorant binding.

Chromium(III) chloride

10025-73-7sc-239548
sc-239548A
sc-239548B
25 g
100 g
1 kg
$68.00
$272.00
$2462.00
(0)

Binds to olfactory receptors, potentially changing the receptor conformation and inhibiting the normal function of Olfr312.

Ethylene glycol

107-21-1sc-257515
sc-257515A
500 ml
1 L
$83.00
$118.00
1
(1)

Interferes with receptor function by altering cell membrane properties where Olfr312 may be located, inhibiting normal receptor activity.